Am J Transplant, Volume 16, Suppl 3 Archives - Page 26 of 180 - ATC Abstracts

2016 American Transplant Congress
Early Onset Hyperuricemia Is a Prognostic Marker for Kidney Allograft Dysfunction.
M. Han,¹ S. Yang,² I. Jung,³ S.-K. Park,⁴ Y. Kim,⁵ D. Han,⁵ Y. Kim,¹ S. Kim,⁶ J. Lee.⁷
¹Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; ²Kidney Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; ³Department of Surgery, Seoul National University Boramae Medical Center, Seoul, Republic of Korea; ⁴Department of Internal Medicine, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea; ⁵Department of Surgery, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea; ⁶Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea; ⁷Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Aim: It is not certain whether hyperuricemia is a true risk factor of kidney allograft failure. We investigated the association of hyperuricemia and graft outcome.Methods:…
2016 American Transplant Congress
Should Obese Patients Undergo Renal Transplantation? A Retrospective Analysis to Assess Whether Body Mass Index Can Affect Transplant Outcome.
A. Mehta,¹ A. Marriott,¹ A. Ghazanfar.²
¹St. George's, University of London, London, United Kingdom; ²Renal Transplant Unit, St. George's Hospital, London, United Kingdom.
This study aims to analyze our renal transplant recipient population in terms of perioperative complications (90 day) and graft survival (3 years) in relation to…
2016 American Transplant Congress
Association Between GFR Decline and Long Term Outcome in Renal Transplantation.
A. Delay,¹ O. Moranne,² N. Maillard,¹ E. Alamartine,¹ C. Mariat.¹
¹Nephrology Department, CHU, Saint Etienne, France; ²Nephrology Department, CHU, Nimes, France.
In renal transplantation, GFR decline is strongly associated to graft failure and patient death and thus could be an interesting proxy for clinical research. GFR…
2016 American Transplant Congress
Chemoprevention of Cutaneous Squamous Cell Carcinoma in Renal Transplant Recipients: A Case-Controlled Analysis.
R. Anand, R. Hung, S. Frame, K. Bramham, M. Wain, A. Cronin.
Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom.
Organ transplant recipients are up to 200 times more likely to develop cutaneous squamous cell carcinoma (SCC) than age-matched general populations. Systemic retinoids, such as…
2016 American Transplant Congress
Donor Risk Index for Intestinal & Multi-Visceral Transplantation.
G. Zeng,¹ M. Chen,² X. Zhao,³ D. Landsittel,² H. Sogawa.⁴
¹Department of Pathology, The Thomas E Starzl Transplantation Institute, Pittsburgh, PA; ²Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, School of Medicine, Pittsburgh, PA; ³Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China; ⁴Multi-Organ Transplant & Hepatobiliary, Westchester Medical Center, Valhalla, NY.
Background: The Donor Risk Index and the Kidney Donor Profile Index (KDPI) have been utilized for liver and kidney transplantation in clinical and research setting.…
2016 American Transplant Congress
Eomesodermin Expression by CD8+ Alloreactive T Cells in Human and Nonhuman Primate Allograft Recipients.
A. Perez-Gutierrez, L. Lu, A. Zahorchak, Y. Ono, A. Thomson, M. Ezzelarab.
Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA.
Background:The transcription factor Eomesodermin (Eomes) is critical in the maintenance of antigen-specific memory T cells (Tmem). We have shown previously that prolonged kidney allograft survival…
2016 American Transplant Congress
Belatacept Immunotherapy Is Not Augmented by Blockade of Activated LFA-1 in a Nonhuman Primate Renal Transplant Model.
K. Samy,¹ M. Mulvihill,¹ B. Collins,¹ D. Lo,² M. Song,¹ F. Leopardi,¹ A. Kirk.^1,2
¹Department of Surgery, Duke University Medical Center, Durham, NC; ²Emory University, Atlanta, GA.
Purpose: Belatacept specifically targets de novo alloimmune responses without off target side effects. However, resistant alloreactive memory T cells have complicated its use. LFA-1 therapy…
2016 American Transplant Congress
One-Year Graft Loss Risk in Kidney Transplants – A Big Data Approach.
T. Srinivas, D. Taber, J. Zhang, Z. Su, J. Marsden, A. Tripathi, W. Moran, P. Mauldin.
MUSC, Charleston, SC; IBM Corp., Armonk.
Background Predictive models using national data are limited by lack of evolving patient level data. A Big Data approach using both static and dynamic variables…
2016 American Transplant Congress
Similar Kidney Allograft and Patient Survival in Native Americans Despite Lower Rates of Living Donation and Longer Wait on the Deceased Donor List.
H. Khamash,¹ K. Reddy,² H. Chakkera,¹ J. Huskey,¹ S. Sukumaran-Nair,¹ A. Mathur,² A. Moss,² N. Katariya,² A. Singer,² R. Heilman.¹
¹Nephrology, Mayo Clinic Arizona, Phoenix; ²Transplant Surgery, Mayo Clinic Arizona, Phoenix.
Previous studies have shown that Native Americans (NAs) have decreased access and inferior outcomes following kidney transplantation. Reviewing our center's experience we wanted to assess…
2016 American Transplant Congress
Impediments to Timely Listing for HIV+ Patients Being Evaluated for Kidney Transplantation.
D. Lee,¹ A. Aldea,¹ M. Harhay,² S. Akshay,² G. Malat,³ N. Law,¹ S. DeBellis,² T. Bias,¹ S. Boyle,² K. Ranganna,² A. Doyle.²
¹Division of Infectious Diseases and HIV Medicine, Drexel University, Philadelphia; ²Division of Nephrology, Drexel University, Philadelphia; ³Department of Surgery, Drexel University, Philadelphia.
Introduction:HIV+ individuals can be transplanted safely and effectively but face additional barriers in evaluation and listing.MethodsWe performed a single center chart review of all HIV+…